TrialJournal of the American Heart Association2023

Thrombocytopenia as a Bleeding Risk Factor in Atrial Fibrillation and Coronary Artery Disease: Insights From the AFIRE Study.

Raisuke Iijima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.